Company / Shares Outstanding
Jazz Pharmaceuticals Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
60.6M
FY2025
5-year range
56.2M / 63.2M
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
#145 of 212
Health Care
What the data says
At 60631000.00, Jazz Pharmaceuticals's shares outstanding ranks #68 of 212 in the Health Care sector. Improved from 63214000.00 to 60631000.00 over the past 2 years.
Based on SEC 10-K filings.
60631000.00 in FY2025 with a 5-year CAGR of +1.6%.
Improved from 63214000.00 to 60631000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.5%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
#68 of 212 in Health CareTop 32% of 212This company 60.6M Sector average 306.0M
▼
-80.2% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 2.6% year-over-year.
- Ranks #145 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2023.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 60.6M | -2.6% |
| FY2024 | 62.3M | -1.5% |
| FY2023 | 63.2M | +2.6% |
| FY2022 | 61.6M | +9.7% |
| FY2021 | 56.2M | +0.1% |
| FY2020 | 56.1M | -2.7% |
| FY2019 | 57.7M | -2.0% |
| FY2018 | 58.9M | -1.5% |
| FY2017 | 59.8M | -2.4% |
| FY2016 | 61.3M | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026